Nanjing Hicin Pharmaceutical Co., Ltd. (SHE:300584)
China
· Delayed Price · Currency is CNY 42.83
+0.92 (2.20%)
At close: Mar 10, 2026
SHE:300584 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 44.78 | 40.22 | 36.32 | 32.45 | 285.88 | 55.23 | Upgrade
|
| Depreciation & Amortization | 52.85 | 52.85 | 53.56 | 48.14 | 37.06 | 31.55 | Upgrade
|
| Other Amortization | 0.08 | 0.08 | - | - | 0.01 | 0.08 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.79 | 0.95 | 0.02 | 0.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.09 | 2.09 | 0.04 | 0.92 | 2.56 | 3.65 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0 | -0 | -0.06 | -1.05 | -306.42 | -0.3 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.85 | -0.85 | 1.65 | 4.07 | - | - | Upgrade
|
| Other Operating Activities | 26.9 | 16.92 | 12.96 | 11.15 | 6.51 | 6.29 | Upgrade
|
| Change in Accounts Receivable | -49.87 | -49.87 | -31.52 | -121.75 | -37.4 | -1.26 | Upgrade
|
| Change in Inventory | -13.44 | -13.44 | -22 | -9.37 | 17.48 | 1.1 | Upgrade
|
| Change in Accounts Payable | 17.76 | 17.76 | -19.33 | 57.12 | 16.15 | -20.39 | Upgrade
|
| Operating Cash Flow | 74.5 | 59.96 | 23.93 | -5.82 | 59.94 | 73.39 | Upgrade
|
| Operating Cash Flow Growth | 53.92% | 150.54% | - | - | -18.32% | -24.56% | Upgrade
|
| Capital Expenditures | -75.48 | -77.94 | -197.22 | -218.94 | -94.41 | -120.1 | Upgrade
|
| Sale of Property, Plant & Equipment | 59.08 | 0.01 | 0.65 | 0.08 | 0.04 | 0.18 | Upgrade
|
| Investment in Securities | -8.1 | 0 | 59.31 | 247.98 | 8.8 | -9.68 | Upgrade
|
| Investing Cash Flow | -24.5 | -77.93 | -137.27 | 29.12 | -85.57 | -129.6 | Upgrade
|
| Short-Term Debt Issued | - | 73.6 | 29.38 | 283.97 | 145 | - | Upgrade
|
| Long-Term Debt Issued | - | 273.5 | 305.2 | 49 | 49.18 | 175 | Upgrade
|
| Total Debt Issued | 311.1 | 347.1 | 334.58 | 332.97 | 194.18 | 175 | Upgrade
|
| Short-Term Debt Repaid | - | -73.47 | - | - | -135 | - | Upgrade
|
| Long-Term Debt Repaid | - | -260.1 | -263.04 | -338.55 | -0.08 | -129 | Upgrade
|
| Total Debt Repaid | -315.87 | -333.57 | -263.04 | -338.55 | -135.08 | -129 | Upgrade
|
| Net Debt Issued (Repaid) | -4.77 | 13.53 | 71.54 | -5.58 | 59.1 | 46 | Upgrade
|
| Common Dividends Paid | -19.71 | -13.85 | -6.47 | -35.5 | -22.02 | -36.99 | Upgrade
|
| Other Financing Activities | 12.42 | 17.24 | - | -0.95 | - | - | Upgrade
|
| Financing Cash Flow | -12.07 | 16.91 | 65.07 | -42.03 | 37.08 | 9.01 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.01 | -0.01 | 0.02 | 0.01 | -0.06 | 0.01 | Upgrade
|
| Net Cash Flow | 37.95 | -1.06 | -48.25 | -18.73 | 11.39 | -47.19 | Upgrade
|
| Free Cash Flow | -0.98 | -17.98 | -173.29 | -224.76 | -34.47 | -46.71 | Upgrade
|
| Free Cash Flow Margin | -0.16% | -3.56% | -33.46% | -42.69% | -5.96% | -6.61% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.15 | -1.44 | -1.87 | -0.29 | -0.39 | Upgrade
|
| Cash Income Tax Paid | 67.97 | 46.54 | 82.79 | 67.18 | 83.26 | 101.32 | Upgrade
|
| Levered Free Cash Flow | 27.6 | -15.15 | -176.9 | -232.9 | 21.51 | -70.62 | Upgrade
|
| Unlevered Free Cash Flow | 32.03 | -9.54 | -171.73 | -228.36 | 26.19 | -66.24 | Upgrade
|
| Change in Working Capital | -51.34 | -51.34 | -81.32 | -102.45 | 34.31 | -23.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.